Literature DB >> 15378223

Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report.

Gaëlle Hardy1, Françoise Stanke-Labesque, Claudine Contamin, Françoise Serre-Debeauvais, François Bayle, Philippe Zaoui, Germain Bessard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15378223     DOI： 10.1007/s00228-004-0824-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  18 in total

1.  Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.

Authors:  A M Sheikh; D C Wolf; E Lebovics; R Goldberg; H W Horowitz
Journal:  Transplantation       Date:  1999-07-27       Impact factor: 4.939

2.  Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV).

Authors:  R Schvarcz; G Rudbeck; G Söderdahl; L Ståhle
Journal:  Transplantation       Date:  2000-05-27       Impact factor: 4.939

3.  Marked elevation of blood cyclosporin and tacrolimus levels due to concurrent metronidazole therapy.

Authors:  K Herzig; D W Johnson
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

4.  Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir.

Authors:  A Hsu; G R Granneman; G Cao; L Carothers; T el-Shourbagy; P Baroldi; K Erdman; F Brown; E Sun; J M Leonard
Journal:  Clin Pharmacol Ther       Date:  1998-04       Impact factor: 6.875

5.  Pharmacokinetic interaction between saquinavir and cyclosporine.

Authors:  K Brinkman; F Huysmans; D M Burger
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

6.  Diltiazem increases tacrolimus concentrations.

Authors:  M F Hebert; A Y Lam
Journal:  Ann Pharmacother       Date:  1999-06       Impact factor: 3.154

7.  The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.

Authors:  Ashok Kumar B Jain; Raman Venkataramanan; Ron Shapiro; Velma P Scantlebury; Santosh Potdar; C Andrew Bonham; Margaret Ragni; John J Fung
Journal:  Liver Transpl       Date:  2002-09       Impact factor: 5.799

8.  Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients.

Authors:  Ashokkumar B Jain; Raman Venkataramanan; Bijan Eghtesad; Amadeo Marcos; Margaret Ragni; Ron Shapiro; Ann B Rafail; John J Fung
Journal:  Liver Transpl       Date:  2003-09       Impact factor: 5.799

9.  Tacrolimus and lopinavir/ritonavir interaction in liver transplantation.

Authors:  Kristine S Schonder; Michael A Shullo; Olanrewaju Okusanya
Journal:  Ann Pharmacother       Date:  2003-12       Impact factor: 3.154

Review 10.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447
View more
  2 in total

1.  Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir.

Authors:  Markus Bickel; Evrim Anadol; Martin Vogel; Wolf Peter Hofmann; Nils von Hentig; Johannes Kuetscher; Michael Kurowski; Christian Moench; Tessa Lennemann; Thomas Lutz; Wolf Otto Bechstein; Hans Reinhard Brodt; Jürgen Rockstroh
Journal:  J Antimicrob Chemother       Date:  2010-03-04       Impact factor: 5.790

Review 2.  Drug Interactions between Antimicrobial and Immunosuppressive Agents in Solid Organ Transplant Recipients.

Authors:  Vikas Bhagat; Rahul A Pandit; Shwetha Ambapurkar; Manju Sengar; Atul P Kulkarni
Journal:  Indian J Crit Care Med       Date:  2021-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.